Q4 2021 Holdings
Filed 2022-02-14 | 107 holdings | $1.6B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $114.0M | 286,600 | 7.3% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $89.8M | 833,750 | 5.7% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $85.0M | 6,389,538 | 5.4% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $84.7M | 391,920 | 5.4% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $66.3M | 1,503,700 | 4.2% |
| Danaher Corporation(DHR)A | COM | 235851102 | $56.0M | 170,053 | 3.6% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $55.3M | 949,224 | 3.5% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $54.3M | 403,678 | 3.5% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $47.4M | 1,125,465 | 3.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)A | COM | G11196105 | $43.4M | 315,129 | 2.8% |
| ARK ETF TR(ARKG) | GENOMIC REV ETF | 00214Q302 | $40.7M | 664,484 | 2.6% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $38.3M | 849,298 | 2.4% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $35.6M | 10,573,302 | 2.3% |
| Mckesson Corp(MCK)A | COM | 58155Q103 | $33.9M | 136,111 | 2.2% |
| Astrazeneca PLC(AZN)CallA | SPONSORED ADR | 046353108 | $33.3M | 572,300 | 2.1% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $30.9M | 6,440,572 | 2.0% |
| Ishares TR(IWM)PutA | RUSSELL 2000 ETF | 464287655 | $27.8M | 125,000 | 1.8% |
| Ishares TR(IWO)PutA | RUS 2000 GRW ETF | 464287648 | $26.4M | 90,000 | 1.7% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $25.0M | 567,205 | 1.6% |
| Celldex Therapeutics Inc New(CLDX)A | COM NEW | 15117B202 | $22.9M | 592,478 | 1.5% |
| Vertex Pharmaceuticals Inc(VRTX)CallA | COM | 92532F100 | $20.7M | 94,100 | 1.3% |
| Ortho Clinical Diagnostics HA | ORD SHS | G6829J107 | $19.0M | 886,140 | 1.2% |
| R1 RCM IncA | COM | 749397105 | $18.7M | 733,132 | 1.2% |
| Centene Corp del(CNC)A | COM | 15135B101 | $18.5M | 224,613 | 1.2% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $18.4M | 2,301,498 | 1.2% |
| Community Health SYS Inc New(CYH)CallA | COM | 203668108 | $17.0M | 1,277,200 | 1.1% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $16.1M | 51,867 | 1.0% |
| Anthem Inc(ELV)A | COM | 036752103 | $15.9M | 34,294 | 1.0% |
| ARK ETF TR(ARKG)CallA | GENOMIC REV ETF | 00214Q302 | $14.9M | 243,800 | 1.0% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $14.9M | 254,790 | 1.0% |
| Healthequity Inc(HQY)A | COM | 42226A107 | $14.7M | 333,352 | 0.9% |
| Laboratory Corp Amer HldgsA | COM NEW | 50540R409 | $14.3M | 45,522 | 0.9% |
| Spdr SER TR(XBI)CallA | S&P BIOTECH | 78464A870 | $12.7M | 113,800 | 0.8% |
| Humana Inc(HUM)A | COM | 444859102 | $12.7M | 27,382 | 0.8% |
| HCA Healthcare Inc(HCA)A | COM | 40412C101 | $12.6M | 49,094 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR)A | COM | 46116X101 | $12.1M | 231,787 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $11.9M | 70,240 | 0.8% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $11.7M | 384,789 | 0.7% |
| ARK ETF TR(ARKK)A | INNOVATION ETF | 00214Q104 | $11.3M | 119,118 | 0.7% |
| Nanostring Technologies Inc(NSTGEUR)A | COM | 63009R109 | $11.2M | 265,695 | 0.7% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $10.0M | 100,334 | 0.6% |
| Magellan Health IncA | COM NEW | 559079207 | $9.9M | 104,700 | 0.6% |
| Exelixis Inc(EXEL)A | COM | 30161Q104 | $9.8M | 535,700 | 0.6% |
| Natera Inc(NTRA)A | COM | 632307104 | $9.5M | 102,071 | 0.6% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $9.1M | 181,151 | 0.6% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $9.0M | 162,534 | 0.6% |
| Zogenix IncA | COM NEW | 98978L204 | $9.0M | 550,966 | 0.6% |
| Syneos Health Inc(8IN)A | CL A | 87166B102 | $8.8M | 85,612 | 0.6% |
| Irhythm Technologies Inc(IRTC)A | COM | 450056106 | $8.6M | 73,169 | 0.6% |
| Insulet Corp(PODD)A | COM | 45784P101 | $8.0M | 30,172 | 0.5% |